Clinical Trial Update: Neural Response to Inflammatory Challenge in Major Depressive Disorder [Phase 1, Phase 2]

View source ↗

Summary

Ongoing Phase 1/2 clinical trial assessing neural response to an inflammatory challenge in adults with Major Depressive Disorder; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Laureate Institute for Brain Research, Inc. | Conditions: Major Depressive Disorder | Phase 1, Phase 2 | Status: RECRUITING